Why the study?
Does AAV6.ARKct cardiac gene therapy improve cardiac function in a post-MI pig HF model?
Does AAV6.ARKct cardiac gene therapy improve cardiac function in a post-MI pig HF model?
AAV6.ARKct gene therapy demonstrates therapeutic potential for heart failure by improving cardiac function in a clinically relevant large animal model.
No takes yet. Share an insight, caveat, or question.
Should not yet change practice; leaves open therapeutic potential of AAV6.ARKct for future clinical trials.
Raake et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: